Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Long-Term Administration of Oral Losartan on Hepatic Fibrogenesis and Gene Expression in Chronic Hepatitis C With Significant Liver Fibrosis.

NCT00298714 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT00298714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00298714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Long-Term Administration of Oral Losartan on Hepatic Fibrogenesis and Gene Expression in Chronic Hepatitis C With Significant Liver Fibrosis.
Lead sponsor
Hospital Clinic of Barcelona
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2003
Completion date
January 31, 2006
Enrollment
20
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, liver fibrosis